Kodiak Sciences Inc Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
KOD Company Description
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
KOD Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view KOD Smart Score
Score Breakdown
KOD Company Description
Show More
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of KOD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by KOD's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on KOD's company Twitter account
WallStreetBets
Number of mentions of KOD in WallStreetBets Daily Discussion
KOD News
Recent insights relating to KOD
CNBC Recommendations
Recent picks made for KOD stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in KOD
Corporate Flights
Flights by private jets registered to KOD
Our Analysis